Skip to main content

Advertisement

Log in

Risk factors associated with relapse or infectious complications in Japanese patients with microscopic polyangiitis

  • Original Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

The prevention of relapse and infection complications during remission maintenance therapy is required to improve the prognosis of patients with microscopic polyangiitis (MPA) showing rapidly progressive glomerulonephritis (RPGN). The clinicopathological characteristics of patients with ANCA-positive MPA were examined to determine the risk factors for relapse or infectious complications after remission induction therapy.

Patients and methods

The study population consisted of 52 patients diagnosed as ANCA-positive MPA showing RPGN from 2002 to 2012, after publication of the Japanese guideline for RPGN. The clinicopathological findings were examined between the presence and absence of relapse or infectious complications.

Results

The value of vasculitis damage index (VDI) was high for the relapse group and VDI value was identified as the leading factor associated with relapse [hazard ratio (HR) 3.36, 95 % confidence interval (CI) 1.58–7.12, P < 0.01]. On the other hand, the values of Birmingham Vasculitis Activity Score, clinical grade category of RPGN at diagnosis, and VDI at remission were high in the infectious group. Furthermore, clinical grade category of RPGN was the leading factor associated with infectious complications (HR 5.30, 95 % CI 1.41–19.9, P = 0.01).

Conclusion

The disease activity at diagnosis and severity of organ damage at remission were associated with relapse and infectious complications during remission maintenance therapy and infectious complication affected kidney survival and all-cause mortality in patients with ANCA-positive MPA exhibiting RPGN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Churg J, Bernstein J, Glassock RJ. Classification of glomerular disease. In: Churg J, Bernstein J, Glassock RJ editors. Renal disease classification and atlas of glomerular diseases, 2nd ed. New York; 1995. p. 11.

  2. Kitagawa K, Furuichi K, Shinozaki Y, Toyama T, Kitajima S, Hara A, et al. Long-term observations of clinicopathological characteristics and outcome of Japanese patients with pauci-immune crescentic glomerulonephritis. Clin Exp Nephrol. 2013;17:858–65.

    Article  CAS  PubMed  Google Scholar 

  3. Koyama A, Yamagata K, Makino H, Arimura Y, Wada T, Nitta K, et al. A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol. 2009;13:633–50.

    Article  PubMed  Google Scholar 

  4. Walsh M, Merkel PA, Mahr A, Jayne D. Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis. Arthritis Care Res. 2010;62:1166–73.

    Article  Google Scholar 

  5. Ozaki S. ANCA-associated vasculitis: diagnostic and therapeutic strategy. Allergol Int. 2007;56:87–96.

    Article  CAS  PubMed  Google Scholar 

  6. Flossmann O, Bacon P, de Groot K, Jayne D, Rasmussen N, Seo P, Westman K, Luqmani R. Development of comprehensive disease assessment in systemic vasculitis. Ann Rheum Dis. 2007;66:283–92.

    PubMed  Google Scholar 

  7. Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage CO, Adu D. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum. 1997;40:371–80.

    Article  CAS  PubMed  Google Scholar 

  8. Wada T, Hara A, Arimura Y, Sada K-E, Makino H. Risk factors associated with relapse in Japanese patients with microscopic polyangiitis. J Rheumatol. 2012;39:545–51.

    Article  CAS  PubMed  Google Scholar 

  9. Kitajima S, Furuichi K, Sakai N, Sagara A, Shinozaki Y, Toyama T, et al. Relapse and its remission in Japanese patients with idiopathic membranous nephropathy. Clin Exp Nephrol. 2015;19:278–83.

    Article  CAS  PubMed  Google Scholar 

  10. Mukhtyar C, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68:310–7.

    Article  CAS  PubMed  Google Scholar 

  11. Lapraik C, et al. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology. 2007;46:v1615–6.

    Article  Google Scholar 

  12. Ozaki S, Atsumi T, Hayashi T, Ishizu A, Kobayashi S, Kumagai S, et al. Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study. Mod Rheumatol. 2012;22:394–404.

    Article  PubMed  Google Scholar 

  13. Ito-Ihara T, Ono T, Nogaki F, Suyama K, Tanaka M, Yonemoto S, et al. Clinical efficacy of intravenous immunoglobulin for patients with MPO-ANCA-associated rapidly progressive glomerulonephritis. Nephron Clin Pract. 2006;102:c35–42.

    Article  CAS  PubMed  Google Scholar 

  14. Martinez V, Cohen P, Pagnoux C, Vinzio S, Mahr A, Mouthon L, et al. Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients. Arthritis Rheum. 2008;58:308–17.

    Article  CAS  PubMed  Google Scholar 

  15. Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007;18:2180–8.

    Article  CAS  PubMed  Google Scholar 

  16. Szpirt WM, Heaf JG, Petersen J. Plasma exchange for induction and cyclosporine A for maintenance of remission in Wegener’s granulomatosis—a clinical randomized controlled trial. Nephrol Dial Transplant. 2011;26:206–13.

    Article  CAS  PubMed  Google Scholar 

  17. Hasegawa M, Ohashi A, Kabutan N, Hiramatsu S, Kato M, Murakami K, et al. Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic autoantibody-associated vasculitis: a pilot study of 21 patients. Ther Apher Dial. 2006;10:412–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the physicians and staff members at the collaborative institutions for participating in this study and for providing data. This work was financially supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government, for Progressive Renal Diseases Research, Research on Intractable Disease, and for Intractable Vasculitis from the Ministry of Health, Labour and Welfare of the Japanese Government.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Kengo Furuichi.

Ethics declarations

Conflict of interest

The authors declare that no conflicts of interest exist.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kitagawa, K., Furuichi, K., Sagara, A. et al. Risk factors associated with relapse or infectious complications in Japanese patients with microscopic polyangiitis. Clin Exp Nephrol 20, 703–711 (2016). https://doi.org/10.1007/s10157-015-1199-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-015-1199-7

Keywords

Navigation